NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy
Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...
主要な著者: | Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Termedia Publishing House Ltd.
2009
|
類似資料
-
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
著者:: Amandeep Aujla, 等
出版事項: (2019-04-01) -
Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
著者:: Ali Ghassemi, 等
出版事項: (2016-06-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
著者:: Miguel Enrique Cuéllar Mendoza, 等
出版事項: (2024-02-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
著者:: Betül Sevinir, 等
出版事項: (2011-03-01) -
Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
著者:: Betül Sevinir, 等
出版事項: (2011-03-01)